MYC and breast cancer: One explanation for this hTERT down-regulation, which could account for growth inhibition in the breast cancer cells, could be due to a decrease in the downstream target of SIRT1, FOXO3a and c-MYC, which has been shown to increase hTERT expression in a SIRT1-dependent manner [20, 39].